Trial reportThe Kaohsiung journal of medical sciences2025
Effects of Adding Transversus Abdominis Plane Block on Intravenous Nalbuphine and Dexmedetomidine for Severely Pre-Eclamptic Parturients After Cesarean Delivery.
Trial report in The Kaohsiung journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effects of Transverse Abdominis Plane Block with Ropivacaine-Hydromorphone versus. Ropivacaine in Cesarean Section: A Randomized Controlled Trial.Journal of pain research · 2026Trial
- Effects of Adding Transversus Abdominis Plane Block on Intravenous Nalbuphine and Dexmedetomidine for Severely Pre-Eclamptic Parturients After Cesarean Delivery.The Kaohsiung journal of medical sciences · 2025Trial
- Bibliometric Analysis of Patient-Controlled Intravenous Analgesia Research From 2014 to April 2026: Global Trends, Hotspot Evolution, and Future Directions.Pain research & management · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of opioids is frequently associated with the occurrence of adverse effects during cesarean delivery, especially for primiparous women with severe preeclampsia, creating a critical need for investigation of alternative analgesic strategies. The study aims to determine the effects of adding transversus abdominis plane block (TAPB) on patient-controlled intravenous analgesia (PCIA) of nalbuphine (Nal) and dexmedetomidine (Dex) on severely pre-eclamptic parturients after cesarean delivery. This is a randomized controlled trial. Severely pre-eclamptic parturients who were scheduled for elective cesarean delivery with spinal anesthesia were randomly assigned into the TAPB group (TAPB combined with PCIA with Nal and Dex; n = 49) and the PCIA group (same block procedures with normal saline followed by PCIA with Nal and Dex; n = 51). Results showed that adding TAPB to PCIA with Nal and Dex significantly lowered visual analog scale (VAS) scores at rest at 2 and 6 h, at mobilization at 2, 6, and 12 h after surgery, reduced press time of PCIA, shortened time for first feeding and out-of-bed movement, enhanced maternal satisfaction with pain control, and lowered plasma levels of cortisone and norepinephrine. The findings of the study suggest that adding TAPB to PCIA with Nal and Dex could enhance acute recovery with fewer stress responses for severely pre-eclamptic parturients after cesarean delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.